Skip to main content

Lyell Immunopharma, Inc.

LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001806952

In the last 90 days, Lyell Immunopharma, Inc. insiders filed 0 open-market purchases and 10 sales; 87 institutions reported holding it in 13F filings for Q2 2026, worth $178.0M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Lyell Immunopharma, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
+9 vs. Q4 2023
Shares held
132.8M
+1.57M (+1.2%) vs. Q4 2023
Total value
$296.8M
+$41.6M (+16.3%) vs. Q4 2023
New holders
23
36 more added
Sold out
14
45 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LYEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 127 institutions
Q1 2021: 0 institutionsQ2 2021: 52 institutionsQ3 2021: 62 institutionsQ4 2021: 77 institutionsQ1 2022: 79 institutionsQ2 2022: 75 institutionsQ3 2022: 93 institutionsQ4 2022: 95 institutionsQ1 2023: 99 institutionsQ2 2023: 99 institutionsQ3 2023: 106 institutionsQ4 2023: 119 institutionsQ1 2024: 127 institutionsQ2 2024: 120 institutionsQ3 2024: 117 institutionsQ4 2024: 105 institutionsQ1 2025: 112 institutionsQ2 2025: 69 institutionsQ3 2025: 59 institutionsQ4 2025: 69 institutionsQ1 2026: 74 institutionsQ2 2026: 87 institutions
Value heldQ1 2024: $296.8M
Q1 2021: $0Q2 2021: $1.29BQ3 2021: $1.22BQ4 2021: $662.2MQ1 2022: $502.7MQ2 2022: $688.6MQ3 2022: $823.5MQ4 2022: $404.8MQ1 2023: $277.9MQ2 2023: $388.7MQ3 2023: $180.1MQ4 2023: $255.2MQ1 2024: $296.8MQ2 2024: $194.2MQ3 2024: $176.6MQ4 2024: $95.9MQ1 2025: $81.8MQ2 2025: $81.9MQ3 2025: $164.9MQ4 2025: $371.9MQ1 2026: $251.1MQ2 2026: $178.0M
Institutions holding LYEL and their total value by quarter
QuarterHoldersValue
Q2 202687$178.0M
Q1 202674$251.1M
Q4 202569$371.9M
Q3 202559$164.9M
Q2 202569$81.9M
Q1 2025112$81.8M
Q4 2024105$95.9M
Q3 2024117$176.6M
Q2 2024120$194.2M
Q1 2024127$296.8M
Q4 2023119$255.2M
Q3 2023106$180.1M
Q2 202399$388.7M
Q1 202399$277.9M
Q4 202295$404.8M
Q3 202293$823.5M
Q2 202275$688.6M
Q1 202279$502.7M
Q4 202177$662.2M
Q3 202162$1.22B
Q2 202152$1.29B
Q1 20210$0

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Lyell Immunopharma, Inc.; share changes are against Q4 2023.

Institutions holding LYEL in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley545,367$1.22M0.00%−2,230−0.4%Reduced
Canada Pension Plan Investment Board588,235$1.31M0.00%00.0%Unchanged
Bank of New York Mellon Corp633,479$1.41M0.00%−27,538−4.2%Reduced
JPMorgan Chase & Co654,622$1.46M0.00%+492,028+302.6%Added
Baillie Gifford & Co656,157$1.46M0.00%−34,714−5.0%Reduced
Citadel Advisors LLC786,344$1.75M0.00%−2,690,884−77.4%Reduced
Nuveen Asset Management, LLC852,055$1.90M0.00%+122,565+16.8%Added
Invenomic Capital Management LP871,525$1.94M0.10%+125,110+16.8%Added
TD Asset Management Inc963,842$2.15M0.00%+47,610+5.2%Added
Charles Schwab Investment Management Inc1,279,412$2.85M0.00%+12,549+1.0%Added
Northern Trust Corp1,441,970$3.22M0.00%−33,539−2.3%Reduced
Massachusetts Financial Services Co1,540,840$3.44M0.00%+186,162+13.7%Added
MIC Capital Management UK LLP1,740,569$3.88M0.74%00.0%Unchanged
Millennium Management LLC2,036,672$4.54M0.00%+1,137,655+126.5%Added
FMR LLC2,769,262$6.18M0.00%−19,465−0.7%Reduced
SC China Holding Ltd3,045,997$7.43M0.69%00.0%Unchanged
Opaleye Management Inc.3,355,000$7.48M1.63%+3,355,000New
State Street Corp3,717,963$8.29M0.00%+178,877+5.1%Added
Geode Capital Management, LLC4,017,021$8.96M0.00%+79,671+2.0%Added
Alphabet Inc.5,865,125$13.1M0.52%00.0%Unchanged
Price T Rowe Associates Inc6,731,477$15.0M0.00%+92,594+1.4%Added
WuXi AppTec Co., Ltd.8,180,678$18.2M62.06%00.0%Unchanged
Foresite Capital Management IV, LLC8,325,000$18.6M9.38%00.0%Unchanged
Vanguard Group Inc13,388,425$29.9M0.00%−215,602−1.6%Reduced
BlackRock Inc.13,892,627$31.0M0.00%−409,593−2.9%Reduced
Orland Properties Ltd15,093,969$33.7M19.02%00.0%Unchanged
MWG Management Limited20,162,332$45.0M33.29%00.0%Unchanged
HRT Financial LP0$00.00%−496,708−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−225,506−100.0%Sold out
Ieq Capital, LLC0$00.00%−82,157−100.0%Sold out
Point72 Middle East FZE0$00.00%−68,861−100.0%Sold out
Man Group plc0$00.00%−54,202−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−48,775−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−26,101−100.0%Sold out
Rpo LLC0$00.00%−19,739−100.0%Sold out
Aigen Investment Management, LP0$00.00%−15,268−100.0%Sold out
Virtu Financial LLC0$00.00%−15,182−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−13,000−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−8,500−100.0%Sold out
Bear Mountain Capital, Inc.0$00.00%−6,100−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−1−100.0%Sold out
Sawtooth Solutions, LLC––––Not filed